TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT04991636

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Angioscan
Description: La procédure d'étude prévoit de prendre des images pendant une inspiration profonde ainsi que pendant une expiration profonde. Cette deuxième mesure ne nécessite pas l'administration d'une quantité supplémentaire de produit de contraste. Cependant, le temps d'exposition aux rayonnements ionisants est doublé. L'examen utilise une acquisition hélicoïdale en mode rapide. La durée de l'hélice est de l'ordre de 2 secondes en phase d'inspiration, puis il y a un délai de 5 secondes de machine ( demi-tour ) et à nouveau 2 secondes d'exposition en phase d'expiration, soit 4 secondes d'exposition effective aux rayonnements ionisants, le temps de la prise d'image et 9 secondes le temps total de l'examen. l'image et 9 secondes la durée totale de l'examen.
Study: NCT04651166

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Tranexamic acid
Description: 1g tranexamic acid mixed in 100mL saline or lactated ringer

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: 100mL saline or lactated ringers
Study: NCT04747665

Intervention type: OTHER
Intervention: Patient and endoscopist reported experience
Description: Exploration of patient and endoscopists experiences of colonoscopy.

Intervention type: OTHER
Intervention: Patient and endoscopist reported experience
Description: Exploration of patient and endoscopists experiences of colonoscopy.
Study: NCT05574829

Intervention type: DEVICE
Intervention: Esophageal manometry and monitoring of electrical activity of the diaphragm
Description: Esophageal manometry and monitoring of electrical activity of the diaphragm
Study: NCT05337917

Intervention type: PROCEDURE
Intervention: Surgical of the digital nerve
Description: All patients (cases and controls) were subject to surgical repair of digital nerve injury.

Intervention type: PROCEDURE
Intervention: Surgical of the digital nerve
Description: All patients (cases and controls) were subject to surgical repair of digital nerve injury.
Study: NCT04962698

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Visual motor imagery (MI)
Description: Subjects will relax their muscles and perform conventional visual motor imagery (MI). With the guidance of audio instruction, the subjects will imagine the grasp and release motions with the right arm for 2 s in each motion in their mind. There will be no proximal muscle contraction.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Visual motor imagery (MI)
Description: Subjects will relax their muscles and perform conventional visual motor imagery (MI). With the guidance of audio instruction, the subjects will imagine the grasp and release motions with the right arm for 2 s in each motion in their mind. There will be no proximal muscle contraction.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Kinesthetic MI
Description: The same MI procedure as Visual MI will be performed, except that the subjects will focus on the kinesthetic sensation that they would feel with the imagined motions.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Robotic-Hand Interaction with MI
Description: Subjects will perform robotically augmented mental practice for grasp and release motions with the activation control of the proximal muscles. During this task, subjects will also imagine the kinesthetic sensation that they would feel with the corresponding motions with the right arm.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Robotic-Hand Interaction with MI
Description: Subjects will perform robotically augmented mental practice for grasp and release motions with the activation control of the proximal muscles. During this task, subjects will also imagine the kinesthetic sensation that they would feel with the corresponding motions with the right arm.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Robotic-Hand Interaction without MI
Description: Subjects will perform the Robot-Hand Interaction without MI.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Virtual-Hand Interaction
Description: Subjects will interact with visual feedback of virtual robot actions on a monitor.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Robotic Action Observation
Description: Subjects will relax their muscles and focus on observing the computer-controlled grasp and release actions of the robotic hand.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Rest
Description: Subjects will rest without a task.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Rest
Description: Subjects will rest without a task.
Study: NCT05601128

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CAB + RPV
Description: At Day 1 all participants will initiate oral CAB 30 mg + RPV 25 mg once daily for at least 28 days during the Oral Phase. Participants will receive CAB LA 600 mg + RPV LA 900 mg IM injections at month 1 visit followed by CAB LA 400 mg + RPV LA 600 mg IM injections monthly at M2, M3, M4 and M5 visits. Then, starting at month 6 visit, participants will receive CAB LA 600 mg + RPV LA 900 mg IM injections every 2 months at M6, M8, M10 and M12.
Study: NCT05840562

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Capsaicin
Description: Application of capsaicin patches 179 mg

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Duloxetine
Description: Administration of duloxetine
Study: NCT06001541

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Web-SUCCEED
Description: web-SUCCEED (Web-based Self-management Using Collaborative Coping EnhancEment in Diseases), a theoretically-derived, dyadic, self-management program.20,21 Web-SUCCEED is designed to improve self-management by improving dyadic stress coping and strengthening collaboration and communication.21 Web-SUCCEED comprises: 1) a three-module, self-paced behavioral intervention that Veterans and caregivers complete individually (one audio/video module per week) on the web-SUCCEED website; 2) brief, staff-led telephone calls in which dyads participate simultaneously after each module; and 3) peer support via a study-specific discussion board. Dyads learn and practice cognitive behavioral skills to reduce individual and relationship stress; improve positive emotions; improve communication and collaboration; increase pleasant activities; and maintain behavior change.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Web-SUCCEED
Description: web-SUCCEED (Web-based Self-management Using Collaborative Coping EnhancEment in Diseases), a theoretically-derived, dyadic, self-management program.20,21 Web-SUCCEED is designed to improve self-management by improving dyadic stress coping and strengthening collaboration and communication.21 Web-SUCCEED comprises: 1) a three-module, self-paced behavioral intervention that Veterans and caregivers complete individually (one audio/video module per week) on the web-SUCCEED website; 2) brief, staff-led telephone calls in which dyads participate simultaneously after each module; and 3) peer support via a study-specific discussion board. Dyads learn and practice cognitive behavioral skills to reduce individual and relationship stress; improve positive emotions; improve communication and collaboration; increase pleasant activities; and maintain behavior change.
Study: NCT05100810

Intervention type: OTHER
Intervention: Natural History Study
Description: Longitudinal assessment of disease progression of Angelman syndrome in patients
Study: NCT05833659

Intervention type: PROCEDURE
Intervention: The breast reconstruction method after single-port insufflation endoscopic nipple-sparing mastectomy
Description: Group A:The prepectoral breast reconstruction. Group B:The subpectoral breast reconstruction

Intervention type: PROCEDURE
Intervention: The breast reconstruction method after single-port insufflation endoscopic nipple-sparing mastectomy
Description: Group A:The prepectoral breast reconstruction. Group B:The subpectoral breast reconstruction
Study: NCT05947435

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tranexamic acid
Description: Tranexamic acid was administered in intravenous or locally within irrigation fluid

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tranexamic acid
Description: Tranexamic acid was administered in intravenous or locally within irrigation fluid
Study: NCT05975918

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Motivational İnterview
Description: Participants in the experimental group will be informed about the study through pre-interviews and data (Caregiver Descriptive Characteristics Form, Patient Descriptive Characteristics Form, Depression Anxiety and Stress Scale (DASS-21), Coping Attitudes Assessment Scale) will be collected through pre-tests. A motivational interview intervention consisting of a total of 6 interviews will be conducted.

Intervention type: OTHER
Group type: OTHER
Intervention: Psychoeducation
Description: 2 hours of training on coping with stress and problem solving skills will be provided.
Study: NCT05143112

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Allogeneic CD19 CR-T cell
Description: Allogeneic CD19 CR-T cell infusion
Study: NCT04811326

Intervention type: RADIATION
Group type: ACTIVE_COMPARATOR
Intervention: NB-UVB
Description: radiation

Intervention type: RADIATION
Group type: ACTIVE_COMPARATOR
Intervention: NB-UVB
Description: radiation

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Latanoprost
Description: eye drops

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Latanoprost
Description: eye drops
Study: NCT06052644

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Exercise Dose-Response
Description: The intervention will last for 12 weeks. Depending on the group, participants will engage in the intervention either four times a week or only two times, with the duration ranging from 30 to 60 minutes per session. Each session will consist of three phases: an initial warm-up phase, a central phase, and a cool-down phase.~The warm-up phase will focus on joint mobility, beginning with flexion-extension, rotation, and lateral neck flexion while maintaining eye contact with a fixed point. This will be followed by trunk mobility exercises, including rotations.~The central phase will consist of aerobic and strength training performed at an intensity of 80-85% of the maximum heart rate. Each exercise will be performed intensely for 20 to 30 seconds, followed by a rest period of 10 to 15 seconds before repeating the exercise.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Exercise Dose-Response
Description: The intervention will last for 12 weeks. Depending on the group, participants will engage in the intervention either four times a week or only two times, with the duration ranging from 30 to 60 minutes per session. Each session will consist of three phases: an initial warm-up phase, a central phase, and a cool-down phase.~The warm-up phase will focus on joint mobility, beginning with flexion-extension, rotation, and lateral neck flexion while maintaining eye contact with a fixed point. This will be followed by trunk mobility exercises, including rotations.~The central phase will consist of aerobic and strength training performed at an intensity of 80-85% of the maximum heart rate. Each exercise will be performed intensely for 20 to 30 seconds, followed by a rest period of 10 to 15 seconds before repeating the exercise.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Exercise Dose-Response
Description: The intervention will last for 12 weeks. Depending on the group, participants will engage in the intervention either four times a week or only two times, with the duration ranging from 30 to 60 minutes per session. Each session will consist of three phases: an initial warm-up phase, a central phase, and a cool-down phase.~The warm-up phase will focus on joint mobility, beginning with flexion-extension, rotation, and lateral neck flexion while maintaining eye contact with a fixed point. This will be followed by trunk mobility exercises, including rotations.~The central phase will consist of aerobic and strength training performed at an intensity of 80-85% of the maximum heart rate. Each exercise will be performed intensely for 20 to 30 seconds, followed by a rest period of 10 to 15 seconds before repeating the exercise.
Study: NCT05293197

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: SonoCloud® (9 transducers)
Description: SonoCloud®, sonication: dose escalation 6 cycles of sonication
Study: NCT04793373

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Syringe
Description: A syringe will be used to detect the loss of resistance and needle's entry of epidural space.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Syringe
Description: A syringe will be used to detect the loss of resistance and needle's entry of epidural space.
Study: NCT06128213

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: NRX101 (a fixed dose combination of D-cycloserine (DCS) and lurasidone HCl (lurasidone))
Description: oral NRX-101 (a fixed dose combination of 487.5 mg D-cycloserine (DCS) and 16.5 mg lurasidone HCl (lurasidone) twice daily for 10 days
Study: NCT05313906

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: RC48+AK105+cisplatin
Description: RC48 plus AK105 and cisplatin
Study: NCT05609799

Intervention type: OTHER
Group type: OTHER
Intervention: Blood sample
Description: Quantifying the volume of leucocyte subsets: NK-cells, B-cells, and T-cell subsets, including Treg, Th1, Th2 and Th17 in EDTA
Study: NCT05052710

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AZD4831
Description: Subjects will receive oral doses once daily from Days 2-11.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Midazolam
Description: Subjects will receive oral single doses on Day 1 and Day 11.
Study: NCT06168253

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Safety Behavior Fading for Social Anxiety
Description: Participants are asked to reduce or eliminate safety behaviors via text message reminders and checklists to monitor progress.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Unhealthy Behavior Fading
Description: Participants are asked to reduce or eliminate unhealthy behaviors via text message reminders and checklists to monitor progress.
Study: NCT05005325

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Experimental group(Male)
Description: Hurdle steps Deep squats Inline lunges Shoulder Clearing Active straight leg raise Trunk stability pushup Rotary stability Spinal extension exam Spinal flexion exam

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Experimental group(Female)
Description: Hurdle steps Deep squats Inline lunges Shoulder Clearing Active straight leg raise Trunk stability pushup Rotary stability Spinal extension exam Spinal flexion exam
Study: NCT05575570

Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: EVAR
Description: EVAR stent graft and embolization material CE marked.

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: EVAR
Description: EVAR stent graft and embolization material CE marked.
Study: NCT04469790

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: SIT+WALK
Description: Participants will interrupt their sitting for one week

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: EX
Description: Participants will perform a single bout of exercise and then sit for the remaining time for one week
Study: NCT06454305

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Active cycle of breathing technique
Description: Breathing control, thoracic expansion and forced expiratory training are the three components of ACBT. The purpose of the thoracic expansion phase is to facilitate the release of secretions, enhance ventilation, and supply the necessary volume for forced expiratory breathing. Secretions are moved into the central airways during the forceful expiratory exercise that follows The three stages of ACBT

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Blow Bottle Technique
Description: A 1-liter plastic bottle was filled with water to a height of 10 centimeters for this intervention. The water in the bottle was filled using a 30-cm-long tube that was placed 8 cm down. The participants were instructed to sit on a bed with comfortable position, Hold the bottle with one hand and the tube with the other Blowing Technique, Put the tube in mouth by holding lips firmly, Breath in through nose and out through mouth, Blowing enough water is bubbled, Short Breaks for 2 to 3 mints, When mucus rises up get out of it by coughing or huffing
Study: NCT05088109

Intervention type: DIAGNOSTIC_TEST
Intervention: early mortality prediction using septic shock indices
Description: The Shock Index (SI) is the ratio of pulse rate to systolic blood pressure calculated by dividing pulse rate (beat/min) by systolic blood pressure (mm Hg). The adjusted shock index (ASI) is SI calculated after adjusting the heart rate according to body temperature that 10 beats will be added to the heart rate for every 1.0 °C rise in the body temperature above 37.0 °C. The modified shock index (MSI) is a ratio of heart rate to mean blood pressure (MAP). The DSI is a ratio of heart rate to diastolic blood pressure (DAP).
Study: NCT05238649

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Recombinant SARS-CoV-2 Fusion Protein Vaccine 10μg
Description: The product should be a milky-white suspension for injection. For prevention of SARS-CoV-2 infection.

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Recombinant SARS-CoV-2 Fusion Protein Vaccine 25μg
Description: The product should be a milky-white suspension for injection. For prevention of SARS-CoV-2 infection.

Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: SARS-Cov-2 Vaccine Inactivated
Description: The product should be a milky-white suspension for injection. For prevention of SARS-CoV-2 infection.
Study: NCT06210061

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Propofol-Fentanyl
Description: Anesthesia will be induced with propofol (2mg/kg) and fentanyl (1 ug/kg). Anesthesia will be maintained with propofol and fentanyl infusion, commenced at 10 mg/kg/hr and 0.5 ug/kg/hr respectively and adjusted to keep BIS between 40 \& 50 during surgery. Minimal dose of atracurium 0.1 mg/kg will be given at induction to facilitate intubation.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Propofol-Fentanyl-Dexmedetomidine
Description: Anesthesia will be induced with propofol (2mg/kg) and fentanyl (1 ug/kg). Anesthesia will be maintained with propofol and fentanyl infusion, commenced at 10 mg/kg/hr and 0.5 ug/kg/hr respectively and adjusted to keep BIS between 40 \& 50 during surgery.~In addition patients will receive Dexmedetomidine (0.5ug.kg) loading dose infused over 10 mins followed by a constant infusion rate of (0.2ug/kg/hr). Minimal dose of atracurium 0.1 mg/kg will be given at induction to facilitate intubation.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Propofol-Fentanyl-Sevoflurane
Description: Anesthesia will be induced with propofol (2mg/kg) and fentanyl (1 ug/kg). Anesthesia will be maintained with propofol and fentanyl infusion, commenced at 10 mg/kg/hr and 0.5 ug/kg/hr respectively and adjusted to keep BIS between 40 \& 50 during surgery.~In addition the anesthesia will be maintained with inhalational anesthesia of 50% oxygen , 50% air plus sevoflurane concentration adjusted to keep BIS between 40 \& 50 . Minimal dose of atracurium 0.1 mg/kg will be given at induction to facilitate intubation
Study: NCT06034899

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BMS-986196
Description: Specified dose on specified days

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BMS-986196
Description: Specified dose on specified days

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BMS-986196
Description: Specified dose on specified days

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BMS-986196
Description: Specified dose on specified days
Study: NCT04901845

Intervention type: OTHER
Intervention: No intervention provided
Description: Study is provided in the usual daily practice of the physicians without interventions made in their practice

Intervention type: OTHER
Intervention: No intervention provided
Description: Study is provided in the usual daily practice of the physicians without interventions made in their practice
Study: NCT05172986

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Follow-up patient program
Description: An additional paramedical visit will be carried out before the surgery. The interview is carried out by the healthcare team. An organization within the service has been set up so that a nurse can be totally seconded for the RAAC mission. The consultation lasts 30 to 45 minutes.
Study: NCT06485739

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Irinotecan liposomes combined with cisplatin/carboplatin
Description: Irinotecan liposomes 70mg/m2，use on the first day of each cycle The dosage of cisplatin and carboplatin is determined by the researchers
Study: NCT06189989

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: The group to which a care package was applied in addition to the clinical routine care protocol)
Description: Intervention Group:~* Immediately after the newborn's admission to the intensive care unit, mechanical ventilation mode, physiological parameters, blood gas results and descriptive characteristics of the baby were recorded in the Data Collection and Daily Monitoring Form.~* In addition to the routine care practices of the clinic (every 3 hours / 8 times a day), the newborn's temporary tachypnea care package was applied. Postural drainage, percussion and vibration were applied 4 times a day for an average of 10-15 minutes.~* Mechanical ventilation mode and physiological parameters were recorded one hour after 4 daily maintenance applications.~* Blood gas parameters were evaluated immediately before and 1 hour after the newborn was separated from mechanical ventilation.~* Physiological parameters were recorded again 1 hour after the first routine nursing care after the newborn was separated from mechanical ventilation.
Study: NCT04178811

Intervention type: DEVICE
Intervention: Holmium Laser Enucleation of Prostate
Description: Use of Holmium Laser Enucleation of Prostate in management of Benign Prostatic Hyperplasia patients

Intervention type: DEVICE
Intervention: Holmium Laser Enucleation of Prostate
Description: Use of Holmium Laser Enucleation of Prostate in management of Benign Prostatic Hyperplasia patients